Back

Effect of empagliflozin as add-on therapy on transtubular potassium concentration gradient in patients with type 2 diabetes hospitalized for acute decompensated heart failure

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Acute Heart Failure ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Shunsuke Tamaki

Ehime University Graduate School of Medicine, Toon (Japan)

44 More presentations in this session

Presentation thumbnail
Does cardiac transplant protect against broken hearts?
Doctor A. Isath (Boston, US)
Abstract Slides
Presentation thumbnail
TAC induced cardiac hypertrophy leads to increased levels of circulating microvesicles
Doctor P. Pfeifer (Bonn, DE)
Abstract Slides
Presentation thumbnail
Nitrate induced vasoplegia depletes cardiac energy reserves: a model for acute cardiomyopathy in septic shock?
Doctor W. Watson (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Cause-specific mortality and heart failure readmissions according to the HFA-PEFF algorithm in patients hospitalised for heart failure with preserved ejection fraction
Doctor F. Verbrugge (Brussels, BE)
Abstract Slides
Presentation thumbnail
Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality
Doctor K. Matsushita (Yokohama, JP)
Abstract Slides

Access the full session

Session thumbnail
Acute Heart Failure ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources